PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Diseases, Mayo Clinic, Jacksonville, FL, USA.\', \'Loyola University Chicago, Chicago, IL, USA.\', \'United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA; The Geneva Foundation, 917 Pacific Avenue, Tacoma, WA, USA.\', \'School of Natural Sciences, University of Central Lancashire, Preston, UK.\', \'United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA.\', \'Department of Molecular Pharmacology & Neuroscience, Loyola University Chicago, Chicago, IL, USA.\', \'Infectious Diseases, Mayo Clinic, Jacksonville, FL, USA. Electronic address: Kempaiah.Prakasha@mayo.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0141-8130(21)00920-X10.1016/j.ijbiomac.2021.04.148
?:hasPublicationType
?:journal
  • International journal of biological macromolecules
is ?:pmid of
?:pmid
?:pmid
  • 33915212
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.917
?:rankingScore_hIndex
  • 92
is ?:relation_isRelatedTo_publication of
?:title
  • Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33915212>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33915212>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all